首页> 外文期刊>American journal of Alzheimer's disease and other dementias >Management of aggression, agitation, and psychosis in dementia: focus on atypical antipsychotics.
【24h】

Management of aggression, agitation, and psychosis in dementia: focus on atypical antipsychotics.

机译:痴呆症的攻击性,躁动和精神病的管理:关注非典型抗精神病药。

获取原文
获取原文并翻译 | 示例
           

摘要

The behavioral and psychological symptoms of dementia (BPSD), such as psychosis, agitation, or aggression have a considerable negative impact on the quality of life of both patients and their caregivers. Multiple studies have demonstrated that atypical antipsychotics are efficacious in the treatment of the aggressive and psychotic symptom clusters, and here we review their use in this indication. Because of the safety concerns associated with the use of atypical antipsychotics in this population, these drugs must be used judiciously. For patients with severe BPSD such as psychosis, agitation, or aggression, for whom there are few options, atypical antipsychotics, particularly risperidone and olanzapine, should be considered.
机译:痴呆症(BPSD)的行为和心理症状,例如精神病,躁动或攻击性,对患者及其护理人员的生活质量都有相当大的负面影响。多项研究表明,非典型抗精神病药可有效治疗侵略性和精神病性症状群,在此我们综述其在该适应症中的应用。由于与在该人群中使用非典型抗精神病药有关的安全问题,必须谨慎使用这些药物。对于患有严重BPSD的患者,如精神病,躁动或攻击性,几乎没有选择,应考虑使用非典型抗精神病药,尤其是利培酮和奥氮平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号